Page last updated: 2024-12-11

thiotaurine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thiotaurine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6858023
SCHEMBL ID4927335
MeSH IDM0503106

Synonyms (21)

Synonym
2937-54-4
2-aminoethanethiosulfonic acid
unii-nqz2d7ao62
nqz2d7ao62 ,
einecs 220-918-7
thiotaurine
2-hydroxysulfonothioylethanamine
ethanesulfonothioic acid, 2-amino-, monosodium salt
einecs 250-888-0
31999-89-0
sodium 2-aminosulphonothioacetate
AKOS006342394
AKOS006339614
2-aminoethanesulfonothioic acid
thiotaurine [inci]
SCHEMBL4927335
DTXSID20183602
Q15634190
2-aminoethane-1-sulfonothioic o-acid
DTXSID10863062
2-aminoethane-1-sulfonothioic s-acid

Research Excerpts

Actions

ExcerptReferenceRelevance
"Thiotaurine can produce hydrogen sulfide (H"( A Proteomic Approach to Study the Effect of Thiotaurine on Human Neutrophil Activation.
Baseggio Conrado, A; Canterini, S; Capuozzo, E; Fontana, M; Giarrusso, P; Giorgi, A; SchininĂ , ME,
)
1.11

Toxicity

ExcerptReferenceRelevance
" The results of the currently ongoing trials with CDK4/6 inhibitors will help obtain additional data to evaluate any differences among the different CDK4/6 inhibitors and clarify the weight of TE adverse events in the benefit/risk balance of this new adjuvant strategy."( Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis.
Barbieri, E; Barbolini, M; Canino, F; Cortesi, L; D'Onofrio, R; Dominici, M; Moscetti, L; Omarini, C; Piacentini, F; Sperduti, I; Toss, A, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (31.03)18.7374
1990's0 (0.00)18.2507
2000's4 (13.79)29.6817
2010's9 (31.03)24.3611
2020's7 (24.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.00 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (9.38%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (90.63%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]